tiprankstipranks
Kintara Therapeutics (KTRA)
NASDAQ:KTRA

Kintara Therapeutics (KTRA) Technical Analysis

651 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Kintara Therapeutics’s (KTRA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Kintara Therapeutics is a Sell.
Kintara Therapeutics’s (KTRA) 20-Day exponential moving average is 0.09, while Kintara Therapeutics’s (KTRA) share price is <$0.1, making it a Sell.
Kintara Therapeutics’s (KTRA) 50-Day exponential moving average is 0.18, while Kintara Therapeutics’s (KTRA) share price is <$0.1, making it a Sell.

Kintara Therapeutics (KTRA) Pivot Points

Mar 29, 2024, 06:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.09
0.09
0.09
0.09
0.09
0.09
0.09
Fibonacci
0.09
0.09
0.09
0.09
0.09
0.09
0.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kintara Therapeutics (KTRA) Moving Averages

Mar 29, 2024, 06:37 AM
Period
Simple
Exponential
MA5
0.09Buy
0.09Sell
MA10
0.09Sell
0.09Sell
MA20
0.09Sell
0.09Sell
MA50
0.11Sell
0.18Sell
MA100
0.19Sell
0.62Sell
MA200
2.07Sell
1.77Sell
Kintara Therapeutics’s (KTRA) 10-Day exponential moving average is 0.09, while Kintara Therapeutics’s (KTRA) share price is <$0.1, making it a Sell.
Kintara Therapeutics’s (KTRA) 100-Day exponential moving average is 0.62, while Kintara Therapeutics’s (KTRA) share price is <$0.1, making it a Sell.
Kintara Therapeutics’s (KTRA) stock price is <$0.1 and Kintara Therapeutics’s (KTRA) 50-day simple moving average is 0.11, creating a Sell signal.
Kintara Therapeutics’s (KTRA) stock price is <$0.1 and Kintara Therapeutics’s (KTRA) 100-day simple moving average is 0.19, creating a Sell signal.
Kintara Therapeutics’s (KTRA) stock price is <$0.1 and Kintara Therapeutics’s (KTRA) 200-day simple moving average is 2.07, creating a Sell signal.

Kintara Therapeutics (KTRA) Technical Indicators

Mar 29, 2024, 06:37 AM
Name
Value
Implied Action
RSI (14)
42.32
Neutral
STOCH (9,6)
13.16
Buy
STOCHRSI (14)
17.31
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
20.16
Neutral
Williams %R
-82.69
Buy
CCI (14)
-55.10
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
44.25
Neutral
ROC
0.00
-
Kintara Therapeutics’s (KTRA) Relative Strength Index (RSI) is 42.32, creating a Neutral signal.
Kintara Therapeutics’s (KTRA) Trend Strength Indicator (ADX) is 20.16, creating a Neutral signal.
Kintara Therapeutics’s (KTRA) Commodity Channel Index (CCI) is -55.10, creating a Neutral signal.

FAQ

Is KTRA a Buy, Hold, or Sell?
Based on KTRA’s technical indicators, KTRA is a Sell.
    What is KTRA’s RSI (14)?
    KTRA’s RSI (14) is 42.32, which suggests KTRA is a Neutral.
      What is KTRA’s MACD?
      KTRA’s MACD is >-0.01, which suggests KTRA is a Sell.
        What is KTRA’s 5-day moving average?
        KTRA’s 5-day moving average is 0.09, which suggests KTRA is a Buy.
          What is KTRA’s 20-day moving average?
          KTRA 20-day moving average is 0.09, which suggests KTRA is a Sell.
            What is KTRA’s 50-day moving average?
            KTRA’s 50-day moving average is 0.11, which suggests KTRA is a Sell.
              What is KTRA’s 200-day moving average?
              KTRA’s 200-day moving average is 2.07, which suggests KTRA is a Sell.
                What is KTRA’s Williams % R (14)?
                KTRA’s Williams % R (14) is -82.69, which suggests KTRA is a Buy.
                  What is KTRA’s CCI (14)?
                  KTRA’s CCI (14) is -55.10, which suggests KTRA is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis